Drug Shortage Report for ACT TERBINAFINE

Last updated on 2023-10-03 History
Report ID 111874
Drug Identification Number 02254727
Brand name ACT TERBINAFINE
Common or Proper name TERBINAFINE 250MG TABLET
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TERBINAFINE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-08
Estimated end date
Actual end date 2020-05-31
Shortage status Resolved
Updated date 2023-10-03
Company comments Item is under review to be discontinued - Transitioned
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-04-10 English Compare
v2 2020-04-10 French Compare
v3 2020-05-14 English Compare
v4 2020-05-14 French Compare
v5 2020-06-11 English Compare
v6 2020-06-11 French Compare
v7 2020-08-20 English Compare
v8 2020-08-20 French Compare
v9 2020-12-10 English Compare
v10 2020-12-10 French Compare
v11 2021-02-25 English Compare
v12 2021-02-25 French Compare
v13 2021-04-08 English Compare
v14 2021-04-08 French Compare
v15 2021-05-06 English Compare
v16 2021-05-06 French Compare
v17 2021-05-06 English Compare
v18 2021-05-06 French Compare
v19 2021-05-20 English Compare
v20 2021-05-20 French Compare

Showing 1 to 20 of 31